CorMedix (CRMD)
(Delayed Data from NSDQ)
$11.64 USD
-0.03 (-0.26%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $11.64 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, CorMedix Inc has a market cap of $791.51M, which represents its share price of $11.67 multiplied by its outstanding shares number of 67.82M. As a small-cap company, CRMD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRMD 11.64 -0.03(-0.26%)
Will CRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRMD
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
CRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
Other News for CRMD
March 2026 Options Now Available For CorMedix (CRMD)
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
CRMD Downgraded to Hold by D. Boral Capital | CRMD Stock News
Circle initiated, Disney upgraded: Wall Street's top analyst calls
CorMedix just downgraded at D. Boral Capital, here's why